BMA in Sports Medicine: An Evidence-based Approach in NYC
June 23, 2021
BMA in Sports Medicine: An Evidence-based Approach in NYC
Dr. Jaspal Singh, Vice-Chair and Associate Professor of Weill Cornell’s Department of Rehabilitation Medicine, specializes in providing comprehensive, personalized treatment plans. This, coupled with a growing patient interest, has inspired him to add regenerative medicine expertise to his clinical armamentarium.
Working with RegenMed, and pictured here with Nicolas Tierney, COO, Dr. Singh is developing a series of Circles that support evidence-based clinical decision making in this new field. Components of his Circles will include:
- Institutional IRB approval with a focus on common MSK indications.
- Remote patient monitoring, outcomes capture, and benchmarking for up to two years post-treatment
- Characterization and correlation of specific markers within Human/Cell Tissue Products “HCT/P” assays.
- A regular webinar series, sharing his real-world data results and recommendations with colleagues.
- An open invitation to other “Good Actors” who wish to aggregate and interpret similar real-world data.
To learn more about Dr. Singh’s procedures, Circles, or upcoming webinar series, please contact us.
BMA in Sports Medicine: An Evidence-based Approach in NYC
June 23, 2021
Dr. Jaspal Singh, Vice-Chair and Associate Professor of Weill Cornell’s Department of Rehabilitation Medicine, specializes in providing comprehensive, personalized treatment plans. This, coupled with a growing patient interest, has inspired him to add regenerative medicine expertise to his clinical armamentarium.
Working with RegenMed, and pictured here with Nicolas Tierney, COO, Dr. Singh is developing a series of Circles that support evidence-based clinical decision making in this new field. Components of his Circles will include:
- Institutional IRB approval with a focus on common MSK indications.
- Remote patient monitoring, outcomes capture, and benchmarking for up to two years post-treatment
- Characterization and correlation of specific markers within Human/Cell Tissue Products “HCT/P” assays.
- A regular webinar series, sharing his real-world data results and recommendations with colleagues.
- An open invitation to other “Good Actors” who wish to aggregate and interpret similar real-world data.
To learn more about Dr. Singh’s procedures, Circles, or upcoming webinar series, please contact us.
